Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sarrazin

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Canadian Journal of Psychology|September 1, 1990
Additive latency effects of selective and nonselective restricted priming typesE Buckolz, C Alain, C Sarrazin
Zeitschrift Fur Gastroenterologie|January 9, 1999
[GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance]C Sarrazin, W K Roth, S Zeuzem
European Journal of Gastroenterology & Hepatology|February 12, 1998
Heterosexual transmission of GB virus-C/hepatitis G virus infectionC Sarrazin, W K Roth, S Zeuzem
Alimentary Pharmacology & Therapeutics|April 9, 2010
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapyC M Lange, C Sarrazin, S Zeuzem
Alimentary Pharmacology & Therapeutics|April 14, 2006
Review article: predicting response in hepatitis C virus therapyU Mihm, E Herrmann, C Sarrazin, et al.
Der Urologe. Ausg. A|June 5, 2004
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Radiologe|March 3, 2004
[Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Orthopade|March 24, 2004
[Post-exposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Unfallchirurg|March 31, 2004
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Journal of Clinical Microbiology|July 28, 2001
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2aC Sarrazin, D A Hendricks, F Sedarati, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Canadian Journal of Psychology|September 1, 1990
Additive latency effects of selective and nonselective restricted priming typesE Buckolz, C Alain, C Sarrazin
Zeitschrift Fur Gastroenterologie|January 9, 1999
[GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance]C Sarrazin, W K Roth, S Zeuzem
European Journal of Gastroenterology & Hepatology|February 12, 1998
Heterosexual transmission of GB virus-C/hepatitis G virus infectionC Sarrazin, W K Roth, S Zeuzem
Alimentary Pharmacology & Therapeutics|April 9, 2010
Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapyC M Lange, C Sarrazin, S Zeuzem
Alimentary Pharmacology & Therapeutics|April 14, 2006
Review article: predicting response in hepatitis C virus therapyU Mihm, E Herrmann, C Sarrazin, et al.
Der Urologe. Ausg. A|June 5, 2004
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Radiologe|March 3, 2004
[Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Orthopade|March 24, 2004
[Post-exposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Der Unfallchirurg|March 31, 2004
[Postexposure prevention after occupational exposure to HBV, HCV and HIV]U Sarrazin, R Brodt, C Sarrazin, et al.
Journal of Clinical Microbiology|July 28, 2001
Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2aC Sarrazin, D A Hendricks, F Sedarati, et al.
Pageof 11